1. Pertussis and Adolescents: It’s Time for a Boost A Slide Kit for School Nurses

2. Pertussis Facts  Also known as “whooping cough” or “100-day cough”  Highly contagious  Spread by coughing or sneezing Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine- Preventable Diseases. Atkinson W et al, eds. 9th ed. 2006.

3. Pertussis Facts  Infant vaccinations do not protect for a lifetime  Almost 40% of cases reported in adolescents (10 to 19 years of age) Centers for Disease Control and Prevention. MMWR. 2006;55(RR-3):1-43. Centers for Disease Control and Prevention. Pertussis Surveillance Report—8/12/05.

4. Pertussis Cases Are on the Rise Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W et al, eds. 9th ed. 2006. Centers for Disease Control and Prevention. Pertussis Surveillance Report—8/12/05. 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 22,000 24,000 26,000 Number of Reported Cases Average 1980-1990: 2,900 Cases/year 2004: 25,827 Cases 1980 2004 Year

5. Why Are Adolescents Getting Pertussis?  Protection from vaccination wears off after 5 to 10 years  Close contact in schools helps spread disease Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W et al, eds. 9th ed. 2006. Centers for Disease Control and Prevention. MMWR. 2006;55(RR-3):1-43.

6. What Are the Symptoms of Pertussis in Adolescents?  First symptoms can be like a common cold with cough  Other symptoms may include Coughing fits that last a long time Trouble breathing Vomiting after coughing Whooping sound Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W et al, eds. 9th ed. 2006. Lee GM et al. Clin Infect Dis. 2004;39:1572-1580.

7. Complications of Pertussis in Adolescents  Severe coughing can cause Poor sleep Loss of bladder control Broken ribs  Pertussis can turn into pneumonia Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W et al, eds. 9th ed. 2006.

8. 048121620242832 Adolescents Can Miss Many Days of School  Adolescents with pertussis miss an average of one week of school  Coughing can last an average of 106 days Lee GM et al. Clin Infect Dis. 2004;39:1572-1580. Missed Days of School Range: 0.4 to 32 days

9. Tdap Vaccines Can Help Protect Against Three Serious Diseases Pertussis DiphtheriaTetanus Tdap= tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Centers for Disease Control and Prevention. Vaccine Information Statement—Interim. Tdap Vaccine. Available at http://www.cdc.gov/nip/publications/VIS/vis-dtp.pdf.

10. Why Should Adolescents Get a Tdap Booster Shot?  Adolescents are at increased risk  Adolescents spread disease to other adolescents and to family members, including infants  Safe and effective vaccines are available Centers for Disease Control and Prevention. MMWR. 2006;55(RR-3):1-43.

11. When Should Adolescents Receive a Tdap Booster Shot?  11 to 12 years is the preferred age for Tdap booster  Tdap is also recommended for older adolescents (13 to 18 years of age) Centers for Disease Control and Prevention. MMWR. 2006;55(RR-3):1-43. Centers for Disease Control and Prevention. MMWR. 2005;54(51&52):Q1-Q4.

12. Summary  Pertussis cases have been going up—especially among adolescents  Pertussis spreads very easily  Protection from pertussis wears off 5 to 10 years after vaccination  A Tdap booster can help protect adolescents from pertussis  11 to 12 years is the preferred age for Tdap booster

13. For More Information  Ask your doctor, nurse, or pharmacist  Call your local or state health department  Contact the Centers for Disease Control and Prevention (CDC) Call 1.800.232.4636 Visit the CDC National Immunization Program Web site at www.cdc.gov/nip Centers for Disease Control and Prevention. Vaccine Information Statement—Interim. Tdap Vaccine. Available at http://www.cdc.gov/nip/publications/VIS/vis-dtp.pdf.

14. This slide presentation has been provided by GlaxoSmithKline Vaccines